If you are reading this for yourself, or for a parent, partner, or adult child you are trying to help, you already know how lonely this corner of the valley can feel. Opioid use disorder has reshaped communities across Virginia and the United States over the past two decades. What began as a prescription drug epidemic in the late 1990s evolved into a heroin epidemic when prescription access was restricted, and then into a fentanyl epidemic as illicitly manufactured synthetic opioids became dominant in the street drug supply.
In Roanoke and Southwest Virginia, the opioid crisis has been acute. The Virginia Department of Health has documented significant overdose increases in the region, particularly during and after the COVID-19 pandemic, with fentanyl driving the majority of fatal events in recent years (VDH, 2024).
The clinical reality is that opioid use disorder is treatable, and the evidence behind that statement is overwhelming. The combination of Medication-Assisted Treatment, behavioral therapy, peer community, and family involvement produces durable recovery for clients who engage the work. Our treatment approach grounds the clinical framework, and the level-of-care recommendation is made during the admissions assessment using an ASAM level-of-care assessment.
Understanding Opioid Use Disorder
We name this for every family we talk to, because the shame around opioid use is one of the heaviest reasons people delay treatment. Opioid use disorder is defined in the DSM-5 as a problematic pattern of opioid use leading to clinically significant impairment or distress.
At the neurobiological level, opioids bind to mu-opioid receptors, producing analgesia and euphoria while suppressing the brain’s natural endorphin production. With repeated use, the brain downregulates opioid receptor sensitivity, producing tolerance and, when opioids are removed, a state of neurochemical deficiency that manifests as withdrawal.
At that point, using opioids becomes driven not just by seeking pleasure but by avoiding the profound physical suffering of withdrawal. This is a biological trap, not a moral choice, and the treatment approach is built around that clinical understanding. The person you love did not choose this.
Medication-Assisted Treatment for Opioid Use Disorder
Here is the part we wish more families had access to in plain language. MAT is the evidence-based standard of care for opioid use disorder, endorsed by the Substance Abuse and Mental Health Services Administration, the American Society of Addiction Medicine, the American Medical Association, and the World Health Organization.
The myth that medication is “just trading one drug for another” has cost lives in this country, and we will be direct about that. Medication-Assisted Treatment describes the three FDA-approved medications in detail, with the short summary below.
Buprenorphine (Suboxone, Sublocade, Brixadi)
A partial opioid agonist that reduces cravings and withdrawal symptoms without producing full agonist euphoria at standard doses. Available by prescription from licensed providers. Reduces overdose mortality by 50 percent or more. Dramatically underprescribed relative to regional need.
Naltrexone (Vivitrol)
A full opioid antagonist that blocks all opioid effects. Available as a monthly injectable. Requires full detoxification before initiation.
Methadone
A full opioid agonist administered through federally licensed Opioid Treatment Programs. Highly effective for severe opioid use disorder. By federal law, methadone is dispensed only by certified OTPs; we coordinate referrals to local OTPs and stay in clinical communication with the prescriber.
Medication-Assisted Treatment at Roanoke Refuge
Roanoke Refuge prescribes FDA-approved MAT medications on-site, fully integrated into PHP and IOP. The medication and therapy work as one treatment plan.
For clients who are MAT candidates but not yet on medication, induction happens on-site through our medical team. Buprenorphine (Suboxone, Subutex, Sublocade, Brixadi) and naltrexone (oral and Vivitrol) are prescribed and managed in the same program as the therapy, with the medication and treatment integrated as one plan.
Clients arriving with an existing buprenorphine or naltrexone prescription from another provider can either continue with that provider or transfer their care to our medical team, depending on what fits the situation. For clients best served by methadone, we coordinate with the Roanoke Valley Comprehensive Treatment Center and stay in clinical communication with the prescriber.
Harm Reduction and Naloxone
Naloxone is something we want every family in this valley to carry. Naloxone (sold as Narcan) rapidly reverses opioid overdoseis available without a prescription at most Virginia pharmacies. We provide naloxone education to every client with opioid use disorder and to every family member willing to receive it.
Having it on hand is not a vote against recovery. It is a vote for being prepared in case the worst night comes anyway. In the current fentanyl-saturated drug supply, having naloxone available is not optional. It is a lifesaving tool, and we treat it as a core element of harm reduction inside the family system that surrounds the client.
Detox Before Outpatient Treatment
The fear of withdrawal is the reason many people in active opioid use disorder do not reach out, and that fear is completely understandable. Most clients with opioid use disorder need medically supervised detox or stabilization on buprenorphine or naltrexone before beginning PHP or IOP.
Opioid withdrawal is rarely life-threatening in otherwise healthy adults, but it is acutely and severely physically distressing, and the cravings during withdrawal are the primary driver of return to use. Medical detox happens with our partner providers in the Roanoke Valley; our admissions team coordinates the handoff and, where appropriate, our medical team handles the MAT induction directly on-site. No one walks into withdrawal alone.
Our Clinical Approach to Opioid Use Disorder
Here is what the work looks like once you are stable enough to start. Clients with opioid use disorder are evaluated at intake using an ASAM level-of-care assessment. Once detox or MAT stabilization is complete, the typical entry point is PHP, with a step-down to IOP after two to six weeks of clinical stability. A typical treatment plan combines the following.
- Cognitive Behavioral Therapy — Identifying the thought patterns, environmental triggers, and behavioral patterns specific to opioid use and replacing them with adaptive coping strategies.
- Motivational Interviewing — Strengthening the client’s own reasons for change, particularly during the early phase of treatment when ambivalence is highest.
- Trauma-informed care — Many clients with opioid use disorder carry significant trauma, including from witnessing overdose deaths in their peer community, and the treatment environment is built to hold that.
- Recurrence-prevention planning — Specific to opioid triggers, the high overdose risk during the early weeks after stopping use, and the long arc of opioid recovery.
- Peer recovery support — Peer specialists with lived experience of opioid addiction provide mentorship and connection to community resources across the Roanoke region.
- Family therapy: The relational aftermath of opioid use disorder is significant, and the Family Program structures the work alongside the family.
Dual Diagnosis Considerations
If your story started with a prescription, you are not alone in this room. Co-occurring depression, anxiety, post-traumatic stress disorder, and chronic pain are common in clients with opioid use disorder. Many people developed opioid dependence after a legitimate pain treatment escalated into a dependence pattern, and the underlying pain often remains a real clinical issue alongside the addiction.
Untreated trauma, depression, and anxiety are among the most consistent biological drivers of recurrence of symptoms. Treating the opioid use without treating the underlying mental health condition is like treating the smoke while leaving the fire burning. Our dual diagnosis program addresses both at the same time, and pain management coordination with outside providers is part of the integrated plan when relevant.
Local, regional, and accessible.
Treatment for this substance is delivered from our Salem facility at 1630 Braeburn Drive — just off I-81 exit 137. The Roanoke Valley service area covers Roanoke City, Salem, Vinton, and the surrounding counties of Roanoke, Botetourt, and Bedford. The Salem VA Medical Center sits roughly two miles away and serves as a referral partner for veterans transitioning to civilian outpatient care.
The path in is a single phone call. The admissions team walks through fit, level of care, insurance, and what the first week of treatment will actually look like — at no cost and with no clinical commitment until you are ready. Insurance benefits get verified during the same call. Call (540) 900-0353 to start the conversation.